Pubertal development has recently been evaluated from the standpoint of changes in
insulin-like growth factor (
IGF)-I and IGF-binding protein-3 (IGFBP-3) levels in healthy children. We studied puberty related changes in serum
IGF-I and
IGFBP-3 levels in 24 patients (11 prepubertal) with
insulin dependent diabetes mellitus (
IDDM) and 26 healthy subjects (14 prepubertal). Serum
IGF-I and
IGFBP-3 levels were assayed using immunoradiometric assays and radioimmunoassays, respectively. Serum
IGF-I and
IGFBP-3 levels in diabetics did not increase during puberty, as opposed to those in healthy children. Serum
IGF-I and
IGFBP-3 levels of diabetic patients were found to be lower than those of control subjects during puberty (p < 0.0001 and p < 0.05, respectively). Proteolysis is believed to be a general mechanism to increase IGF bioavailability in the presence of IGFBPs. Increased
IGFBP-3 protease activity has been shown in sera of children with
IDDM as well as a decrease in this activity in response to
insulin therapy. Our data displaying low
IGFBP-3 levels in diabetic children may be due to increased proteolysis, which also causes a shift in
IGF-I to its lower molecular weight forms. Higher rate of clearance of the latter may be the reason for the low
IGF-I levels we observed in children with
IDDM. The moderate correlation between
insulin dose and
IGFBP-3 levels (r = 0.5, p < 0.01) may suggest
insulin to be a contributing factor in the regulation of
IGFBP-3 levels. We conclude that regulation of
IGF-I and
IGFBP-3 concentrations is disturbed in children with
IDDM, in particular during adolescence.